. "Axitinib with or without dose titration for first-line metastatic renal-cell carcinoma: a randomised double-blind phase 2 trial"@en . "Background Population pharmacokinetic data suggest axitinib plasma exposure correlates with efficacy in metastatic renal-cell carcinoma. Axitinib dose titration might optimise exposure and improve outcomes. We prospectively assessed the efficacy and safety of axitinib dose titration in previously untreated patients with metastatic renal-cell carcinoma."@en . . . "AG-013736; volunteers; antiangiogenesis; pharmacokinetics; efficacy; sorafenib; III trial; clinical-trials; solid tumors; interferon-alpha"@en . . "Gr\u00FCnwald, Viktor" . "Pithavala, Yazdi" . "Pavlov, Dmitri" . . "[854192C255E6]" . "1"^^ . "Fishman, Mayer" . . "RIV/61989592:15110/13:33145239" . . . . "10"^^ . . "Jonasch, Eric" . "Background Population pharmacokinetic data suggest axitinib plasma exposure correlates with efficacy in metastatic renal-cell carcinoma. Axitinib dose titration might optimise exposure and improve outcomes. We prospectively assessed the efficacy and safety of axitinib dose titration in previously untreated patients with metastatic renal-cell carcinoma." . "Arranz, Jose" . . "I" . "RIV/61989592:15110/13:33145239!RIV14-MSM-15110___" . . . "Bair, Angel" . "Melichar, Bohuslav" . . . "12" . "Lancet Oncology" . . "Axitinib with or without dose titration for first-line metastatic renal-cell carcinoma: a randomised double-blind phase 2 trial" . "Rini, Brian" . "US - Spojen\u00E9 st\u00E1ty americk\u00E9" . . "Ueda, Takeshi" . "Axitinib with or without dose titration for first-line metastatic renal-cell carcinoma: a randomised double-blind phase 2 trial"@en . "Andrews, Glen" . . . . . "1470-2045" . "15110" . "Kim, Sinil" . "Axitinib with or without dose titration for first-line metastatic renal-cell carcinoma: a randomised double-blind phase 2 trial" . . "10.1016/S1470-2045(13)70464-9" . "14" . "62770" . "12"^^ .